Cresco Labs CRLBF stock & Columbia Care CCHWF stock decide not to merge

Universal genetic testing may improve risk stratification and treatment for rare and lethal cancer

Esophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20 percent. Although a precursor lesion to EAC, called

July 27, 2023

Astellas seeks approval for PADCEV-KEYTRUDA combo

Share this article The sNDA is based on the Phase III EV-302 clinical trial. Credit: totojang1977/ shutterstock.com. Astellas Pharma has submitted a supplemental new drug

January 31, 2024

Expert Pharmaceutical Consulting for Industry Success

Pharmaceutical consulting companies, services and solutions: Introduction In the intricate and highly regulated world of pharmaceuticals, companies are increasingly turning to specialised pharmaceutical consulting firms.

June 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.